AI-generated summary
The authors report a case study of a 47-year-old woman with type 1 diabetes and a severe diabetic foot ulcer treated with photobiomodulation therapy combined with Altrazeal powder. They describe a significant reduction in ulcer area, wound healing within 16 weeks, and reduced pain, and suggest an additive effect. As a single case report, the findings cannot establish general effectiveness and the authors call for further clinical trials.
- Participants
- 1
- Who or what was studied
- A 47-year-old woman with type 1 diabetes and a severe diabetic foot ulcer
- Limits stated in the abstract
- The abstract describes a single patient case report, so the findings cannot be generalized and the authors themselves recommend clinical trials to validate the results.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sbmu.ac.ir.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Case report, Diabetic foot ulcer, Wound healing. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.